Status: Recruiting
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
This phase 2 study is part of regulatory commitments in the United States (PSP) and Europe (PIP) to evaluate cefepime-enmetazobactam in paediatric participants with cUTI to support extension of the indication for cefepime-enmetazobactam to children with cUTI.
Participants needed: 40
Trial details
Phase: Phase 2Age: Up to 18Biological sex: AllType: InterventionalSponsor: Orchid Pharma Europe GmbHUpdated: Aug 20, 2026Locations: 8
Eligibility criteria
Participant must be from birth to <18 years of age. Participants up to 2 months... [+31]
History of serious allergy, hypersensitivity (e.g., anaphylaxis), or any serious... [+18]